LekoskopLekoskop
EN All changes
Medicine recalls and shortages › Recalls and defects › 8 Apr 2025
Medicines recall

Synalar GEL 30g

Issued on 8 Apr 2025 · source: MHRA — Medicines and Healthcare products Regulatory Agency
Affected batches: L303A (31/03/2026), L304A (30/04/2026), L401A (31/03/2027), L403A (31/05/2027), L404A (31/05/2027), L301A (28/02/2026), L402A (31/03/2027)
Check the batch number on the pack. The medicine remains licensed; other batches are not affected.
Class 2 recall · 2 products · DMRC-35165402 · PL: 44095/0004 · licence holder: Reig Jofre UK · active ingredient: Fluocinolone Acetonide 0.025% · licence PL: 44095/0004

What this means

The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.

Class 2 recall · DMRC-35165402

ProductLicenceActive ingredientGTIN
Synalar GEL 30gPL: 44095/0004Fluocinolone Acetonide 0.025%8435373700332
Synalar GEL 60gPL: 44095/0004Fluocinolone Acetonide 0.025%8435373700349

Batches (expiry): L303A (31/03/2026), L304A (30/04/2026), L401A (31/03/2027), L403A (31/05/2027), L404A (31/05/2027), L301A (28/02/2026), L402A (31/03/2027)

Background: It has been identified that the batches listed in this notification of Synalar Gel 30g and 60g contain a residual solvent (benzene) at a level exceeding the ICH limit of 2ppm. This solvent has been identified from one of the excipients in the product, carbomer 940, and the theoretical results from the initial investigation prompted the testing of the retention samples. These results have shown some batches are within the limit, whilst some are over the 2ppm limit. Reig Jofre UK are recalling all these affected batches as a precautionary measure. This recall is at pharmacy and wholesaler level. It is only the specific Synalar Gel batches listed in this notification that are affected. All other presentations of Synalar (Ointment and Cream) are not affected. Due to this recall, there will be a temporary shortage of Synalar Gel and Reig Jofre UK are unable to provide a specific date for wh

Tracked from information published by the MHRA and the NHSBSA. This information is for guidance only and does not replace advice from your doctor or pharmacist.